CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness

Area of Science:

• Vaccinology and Pharmaceutical Sciences
• Biotechnology and Biomedical Engineering

Background:

• The COVID-19 pandemic underscored the need for rapid vaccine development and enhanced preparedness.
• Existing challenges in vaccine development include lengthy timelines and complex regulatory pathways.

Purpose of the Study:

• To provide an overview of critical enablers for accelerating vaccine development and improving pandemic preparedness.
• To identify implementation hurdles and opportunities for sustained acceleration in vaccine innovation.
• To leverage learnings from the COVID-19 pandemic and address unmet medical needs.

Main Methods:

• Review of Chemical, Manufacturing, and Controls (CMC) strategies.
• Analysis of technical innovations in vaccine development platforms.
• Examination of cross-disciplinary frameworks from antigen identification to lifecycle management.
• Assessment of leveraging prior platform knowledge for new vaccine types.
• Evaluation of implementing innovative and digital tools for rapid development and control strategies.

Main Results:

• Key enablers include robust CMC strategies and advanced technical innovations.
• A cross-disciplinary framework is crucial for managing the entire vaccine lifecycle.
• Utilizing prior platform knowledge and digital tools significantly speeds up development.
• Addressing implementation hurdles is vital for sustained acceleration.

Conclusions:

• Sustained acceleration in vaccine development requires a holistic approach integrating technical, strategic, and operational elements.
• Innovation and digital tools are essential for efficient vaccine development and response to future health crises.
• Learnings from the COVID-19 pandemic offer valuable insights for improving global vaccine preparedness.